We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 12, 2020

Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma

Journal of Clinical Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Oncology
Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84)
J. Clin. Oncol 2020 Jul 30;[EPub Ahead of Print], PJ Lugtenburg, P de Nully Brown, B van der Holt, FA D'Amore, HR Koene, E de Jongh, R Fijnheer, JW van Esser, LH Böhmer, JF Pruijt, GE Verhoef, M Hoogendoorn, MY Bilgin, M Nijland, NC van der Burg-de Graauw, M Oosterveld, KG Jie, TS Larsen, MW van der Poel, MB Leijs, MH Silbermann, M van Marwijk Kooy, A Beker, MJ Kersten, JK Doorduijn, LW Tick, RE Brouwer, KH Lam, CN Burggraaff, B de Keizer, AI Arens, D de Jong, OS Hoekstra, JM Zijlstra-Baalbergen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading